Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

FOCIS 2015: Metabolism May Affect Immune System’s Reaction to Disease

Catherine Kolonko  |  Issue: October 2015  |  October 13, 2015

The fighting force of immunological memory is made up of both B cells and T cells, the latter of which can recognize a pathogen after its first encounter and kill it before it has a chance to wreak havoc on the immune system.

“We’ve been very interested in how protective immunity is formed,” said Dr. Goldrath.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The smallpox vaccine is an important example of immune memory, she said. A majority of people who were given the vaccine retain memory T cells that keep them protected against the highly contagious virus “for their entire lifetime for many individuals,” she noted.

Ananda Goldrath, PhD

Dr. Goldrath

Dr. Goldrath and her team set out to explore what allows T cells to transition from effector cells to memory cells that can recognize dangerous repeat invaders. In particular, they wanted to figure out “what has to go right” in the process to ensure activation of the preferred immunity response and the signals involved, she said.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“First and foremost, it’s worth noting that immunological memory is mediated by diverse heterogeneous cell populations,” said Dr. Goldrath. “While a lot of people spent a lot of time trying to tease apart what the signals are that will give immunological memory, it appears that this heterogeneous population is relying on a range of signals.”

It’s possible to conduct experiments and predict whether cells will differentiate to short-lived terminal effectors, which clear initial infection and sustain protection for months to come, or instead generate longlived memory CD8+ T cells that have a renewal capacity and can combat second infection. However, cells are in fact integrating all of the signals early on in the activation process, noted Dr. Goldrath.

Because it is known that T cells in the tissue are exposed to hypoxic signals, Dr. Goldrath and her fellow researchers began to explore inhibitory receptors that are regulated by hypoxia inducible factor (HIF), protein that drives gene expression in response to a reduction of oxygen. At the cellular level, HIF’s immune function is to react whenever oxygen drops to critical levels, signaling genes to respond in various ways to combat the effects of hypoxia.

Researchers looked at connections between hypoxia and transcriptional signals that lead to T cell differentiation. There are a variety of signals that are downstream of HIF, with glycolysis often being the most eminent, Dr. Goldrath said.

Sustained HIF helps power glycolytic activity along the metabolic pathway through a series of changes and transformations. Hypoxia-inducible Factors 1 and 2 also contribute to the glycolytic switch observed during T cell expansion, according to Dr. Goldrath.

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsMeeting Reports Tagged with:ClinicalDiseaseImmune Systemmetabolismoutcomepatient care

Related Articles

    The Expanded Role of the Inflammasome in Human Disease

    August 1, 2010

    Exploring advances, evaluating what remains to be done

    Cryopyrin-Associated Periodic Syndromes: Difficult to Recognize, Diagnose, Treat

    October 1, 2014

    Two case studies demonstrate the difficulty, delay in recognizing this rare autoinflammatory disease

    AJPhoto / Science Source

    Tips for Diagnosing Metabolic Myopathies

    September 17, 2019

    When evaluating patients with possible myopathic symptoms, rheumatologists must consider a rare, but important, group of inherited disorders: the metabolic myopathies. However, their diagnosis often remains a challenge. Early recognition of these primary metabolic myopathies is essential to help prevent disease morbidity and mortality from rhabdomyolysis. Here, we focus on the metabolic myopathies that present…

    2015 ACR/ARHP Annual Meeting: Metabolic Pathways Linked with Inflammatory Diseases

    February 16, 2016

    SAN FRANCISCO—Metabolomics could one day be a treasure map of information about inflammation in rheumatic disease. There are many metabolic pathways to pursue for clues on how to reverse this damaging process. “All of these signaling pathways are interrelated and affect each other,” said Douglas J. Veale, MD, director of translational research at Dublin Academic…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences